Patents by Inventor Thota Ganesh

Thota Ganesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO
    Publication number: 20140179750
    Abstract: The disclosure relates to Prostaglandin receptor EP2 antagonists, derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing conditions and diseases in which EP2 receptor activation has a physiological role, such as but not limited to, brain injury, inflammatory diseases, neuroinflammation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders by administering a pharmaceutical composition comprising a compound disclosed herein to a subject in need thereof.
    Type: Application
    Filed: June 19, 2012
    Publication date: June 26, 2014
    Applicant: EMORY UNIVERSITY
    Inventors: Jianxiong Jiang, Thota Ganesh, Yuhong Du, Pahk Thepchatri, Yi Quan, Ray J. Dingledine
  • QUINAZOLINE DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO
    Publication number: 20130225612
    Abstract: The invention relates to quinazoline derivatives, compositions, and methods related thereto. In certain embodiments, the invention relates to inhibitors of NADPH-oxidase.
    Type: Application
    Filed: May 3, 2012
    Publication date: August 29, 2013
    Applicant: EMORY UNIVERSITY
    Inventors: John David Lambeth, Thota Ganesh, Susan M. Smith, Aiming Sun
  • Conformationally constrained paclitaxel analogs and their use as anticancer and anti-Alzheimers agents
    Patent number: 7312240
    Abstract: Constrained paclitaxel derivatives include a bridge extending from the C-3? phenyl to either the C4 or -3 positions. Many of the constrained paclitaxel derivatives provide activity comparable or superior to the natural product paclitaxel.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: December 25, 2007
    Assignees: Virginia Tech Intellectual Properties, Inc., Binghamton University, Emory University
    Inventors: David George Ian Kingston, Thota Ganesh, James Patrick Synder, Ami S. Lakdawala, Susan Lynn Bane
  • Conformationally constrained paclitaxel analogs and their use as anticancer and anti-alzheimers agents
    Publication number: 20050187287
    Abstract: Constrained paclitaxel derivatives include a bridge extending from the C-3? phenyl to either the C4 or -3 positions. Many of the constrained paclitaxel derivatives provide activity comparable or superior to the natural product paclitaxel.
    Type: Application
    Filed: January 14, 2005
    Publication date: August 25, 2005
    Inventors: David Ian Kingston, Thota Ganesh, James Snyder, Ami Lakdawala, Susan Bane